UNSPSC 51281631: Viomycin

This classification denotes an antitubercular agent with the molecular formula C25H43N13O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, YVU35998K5 chemically known as glycine, 3-amino-n-((3s)-3,6-diamino-1-oxohexyl)-l-alanyl-l-seryl-l-seryl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-2-((4r,6s)-2-amino-1,4,5,6-tetrahydro-6-hydroxy-4-pyrimidinyl)-, (5->13)-lactam, (2s)- but generally known as viomycin, which bears US NIH Compound Identifier 3032902.

UNSPSC 51281631 Viomycin, a Commodity code, nominally covers a specific antibiotic pharmaceutical product, but recent state and local procurement activity under this code shows little alignment with viomycin procurement itself. The opportunities tagged to this code reflect broader pharmaceutical supply and public health procurement, including antibiotic and opioid-antagonist medications sourced through piggyback consortia and direct county health procurements. State and local issuing bodies acquiring under or near this code include state health departments and county health authorities managing emergency preparedness, community health, and pharmaceutical inventory. The work involves competitive pharmaceutical sourcing, contract management through cooperative purchasing vehicles such as MMCAP Infuse, and compliance with drug-free workplace and E-Verify requirements.

Recent activity centers in Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392) for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets, totaling $2,999,999.11 over a three-year term with two renewal options; this was a completed award under an Invitation for Bid process, not an open solicitation. Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to its Community Health Building in Sanford, with a response deadline of July 26, 2026. The code's recent activity is sparse and does not reflect viomycin-specific procurement; vendors should verify whether individual opportunities are actually soliciting products within this Commodity's scope before pursuing.